IRIS
BURONI, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.995
AS - Asia 2.095
EU - Europa 1.924
SA - Sud America 345
AF - Africa 47
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 7.425
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.908
CN - Cina 1.128
IE - Irlanda 490
SG - Singapore 423
BR - Brasile 279
HK - Hong Kong 270
RU - Federazione Russa 263
DE - Germania 235
UA - Ucraina 210
FI - Finlandia 196
IT - Italia 169
GB - Regno Unito 110
SE - Svezia 105
VN - Vietnam 89
CA - Canada 48
FR - Francia 33
AR - Argentina 32
IN - India 32
JP - Giappone 24
MX - Messico 23
PL - Polonia 22
JO - Giordania 19
BD - Bangladesh 18
ES - Italia 15
BE - Belgio 14
IQ - Iraq 14
TR - Turchia 13
AU - Australia 11
CZ - Repubblica Ceca 11
EC - Ecuador 11
ID - Indonesia 11
AT - Austria 10
LT - Lituania 10
ZA - Sudafrica 10
NG - Nigeria 9
NL - Olanda 9
AZ - Azerbaigian 8
CO - Colombia 8
EG - Egitto 8
AE - Emirati Arabi Uniti 5
GR - Grecia 5
MA - Marocco 5
PK - Pakistan 5
UZ - Uzbekistan 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
HU - Ungheria 4
KG - Kirghizistan 4
MU - Mauritius 4
PA - Panama 4
SA - Arabia Saudita 4
VE - Venezuela 4
BO - Bolivia 3
CL - Cile 3
KE - Kenya 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
TN - Tunisia 3
AM - Armenia 2
EU - Europa 2
IL - Israele 2
IR - Iran 2
JM - Giamaica 2
LV - Lettonia 2
MD - Moldavia 2
RO - Romania 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CG - Congo 1
CH - Svizzera 1
DK - Danimarca 1
DZ - Algeria 1
GH - Ghana 1
GM - Gambi 1
GS - Georgia del Sud e Isole Sandwich Australi 1
GT - Guatemala 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MM - Myanmar 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
RS - Serbia 1
TJ - Tagikistan 1
UY - Uruguay 1
Totale 7.425
Salva come PNG Salva come JPEG
Città #
Chandler 489
Dublin 482
Beijing 288
Ashburn 279
Hong Kong 270
Jacksonville 256
Dallas 255
Singapore 235
Nanjing 194
Boardman 136
Los Angeles 93
Helsinki 83
Princeton 80
Lawrence 75
Nanchang 68
Wilmington 67
Medford 64
Pavia 64
Ann Arbor 63
Jiaxing 63
Munich 61
Shenyang 59
Shanghai 56
Changsha 55
New York 54
Hebei 53
Moscow 46
Hangzhou 42
Ho Chi Minh City 42
Buffalo 35
Tianjin 33
Redondo Beach 28
Milan 25
São Paulo 22
Woodbridge 22
Denver 21
Santa Clara 21
The Dalles 21
Tokyo 21
Hanoi 20
San Francisco 19
Amman 18
Brooklyn 18
Turku 18
Warsaw 18
Houston 15
London 15
Norwalk 15
Stockholm 15
Columbus 14
Montreal 14
Brussels 13
Chicago 13
Phoenix 13
Poplar 13
Toronto 13
Boston 12
Frankfurt am Main 12
Seattle 12
Verona 12
Washington 12
Falkenstein 11
Ottawa 11
Rio de Janeiro 11
Brasília 10
Falls Church 10
Mexico City 10
Olomouc 10
Atlanta 9
Fairfield 9
Lagos 9
Baku 8
Manchester 8
Porto Alegre 8
Redwood City 8
Vienna 8
Hyderabad 7
Nuremberg 7
Piscataway 7
Rome 7
Belo Horizonte 6
Council Bluffs 6
Curitiba 6
Des Moines 6
Florence 6
Jakarta 6
Mumbai 6
Orem 6
Providence 6
St Petersburg 6
Baghdad 5
Campinas 5
Chennai 5
Guangzhou 5
Hải Dương 5
Johannesburg 5
Quito 5
Tashkent 5
Auburn Hills 4
Bishkek 4
Totale 4.921
Salva come PNG Salva come JPEG
Nome #
Benzothiazinones Are Suicide Inhibitors of Mycobacterial Decaprenylphosphoryl-β-d-ribofuranose 2'-Oxidase DprE1. 145
Biological and structural characterization of theMycobacterium smegmatis nitroreductase NfnB, and its rolein benzothiazinone resistance 142
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis 135
Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome 130
Analyzing the role of RND efflux transporters in Burkholderia cenocepacia: a proteomic analysis. 129
Decaprenylphosphoryl-β-D-ribose 2’-epimerase from Mycobacterium tuberculosis is a magic drug target 127
A census of RND superfamily proteins in the Burkholderia genus. 127
Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance 126
Differential role of RND efflux pumps in antimicrobial drug resistance of sessile and planktonic Burkholderia cenocepacia cells 125
Antistaphylococcal activity of the ftsz inhibitor c109 125
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis 124
Bactericidal and Anti-Biofilm Activity of the FtsZ Inhibitor C109 against Acinetobacter baumannii 119
Bombas de eflujo como trasportadores de membrana implicados en resistencia a antibióticos en micobacterias 119
Characterization of the mechanism of resistance to BM212, a new potential antitubercular drug. 116
Biochemical Characterization of Glutamate Racemase-A New Candidate Drug Target against Burkholderia cenocepacia Infections 115
Investigating the Mechanism of Action of Diketopiperazines Inhibitors of the Burkholderia cenocepacia Quorum Sensing Synthase CepI: A Site-Directed Mutagenesis Study 115
Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis. 113
Mycobacterium tuberculosis Phosphoribosylpyrophosphate Synthetase: Biochemical Features of a Crucial Enzyme for Mycobacterial Cell Wall Biosynthesis. 110
Discovery of new diketopiperazines inhibiting Burkholderia cenocepacia quorum sensing in vitro and in vivo. 110
Study of the regulation of lfrA gene coding for an antibiotic efflux pump of Mycobacterium smegmatis. 108
Rv2466c mediates the activation of TP053 to kill replicating and non-replicating Mycobacterium tuberculosis. 108
Decaprenylphosphoryl-beta-D-ribose 2’-epimerase from Mycobacterium tuberculosis is a magic drug target. 107
LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis. 106
Mechanism of resistance to an antitubercular 2-thiopyridine derivative that is also active against Burkholderia cenocepacia. 106
Efflux-mediated resistance to a benzothiadiazol derivative effective against Burkholderia cenocepacia 106
Chemical, Metabolic, and Cellular Characterization of a FtsZ Inhibitor Effective Against Burkholderia cenocepacia 106
Espressione, purificazione ed analisi funzionale della NAD+ sintetasi di Mycobacterium tuberculosis, un enzima essenziale 105
LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis 104
Contribution of the Mycobacterium tuberculosis efflux pumps to drug resistance 101
Molecular characterization of the burkholderia cenocepacia dcw operon and ftsz interactors as new targets for novel antimicrobial design 101
Studies on the identification and characterization of the cellular target of the potential antitubercular drug BM212. 100
Competitive fitness of essential gene knockdowns reveals a broad-spectrum antibacterial inhibitor of the cell division protein FtsZ 100
MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212 99
The MmpL3 protein is responsible for resistance to BM212, a lead antitubercular drug. 99
Identification and characterization of the cellular target for benzothiazinones, a new potential antitubercular drug class. 99
Burkholderia cenocepacia infections in cystic fibrosis patients: Drug resistance and therapeutic approaches 97
Structural plasticity and distinct drug-binding modes of LfrR, a mycobacterial efflux pump regulator. 95
Antimicrobial activity of six essential oils against Burkholderia cepacia complex: Insights into mechanism(s) of action 95
CodY Is a Global Transcriptional Regulator Required for Virulence in Group B Streptococcus 93
Deciphering the role of RND efflux transporters in Burkholderia cenocepacia. 92
A new promising bactericidal compound against Burkholderia cenocepacia. 92
Role in benzothiazinone resistance of nitroreductase NfnB of Mycobacterium smegmatis 91
Mycobacterium tuberculosis: drug resistance and future perspectives 91
The cell division protein FtsZ as a cellular target to hit cystic fibrosis pathogens 88
Identification of the cellular target of the potential antitubercular drug BM 212 87
Phenotypic and Genotypic Characterisation of Burkholderia cenocepacia J2315 Mutants Affected in Homoserine Lactone and Diffusible Signal Factor-Based Quorum Sensing Systems Suggests Interplay between Both Types of Systems. 87
Methodological tools to study species of the genus Burkholderia 86
Role of rnd efflux pumps in drug resistance of cystic fibrosis pathogens 85
Rv3790 is the cellular target for benzothiazinones, a new promising antitubercular drug class 81
Study of antibiotic efflux pumps belonging to Resistance-Nodulation-Division (RND) family in Burkholderia cenocepacia. 80
AI is a viable alternative to high throughput screening: a 318-target study 79
Glutamine amidotransferase activity of NAD+ synthetase from Mycobacterium tuberculosis depends on an amino-terminal nitrilase domain. 79
Antivirulence compounds: a future direction to overcome antibiotic resistance? 78
Fighting against resistant strains: the case of benzothiazinones and dinitrobenzamides 78
Molecular basis for antibiotic resistance in the genus Burkholderia 77
Characterization of the dispirotripiperazine derivative PDSTP as antibiotic adjuvant and antivirulence compound against Pseudomonas aeruginosa 76
Deciphering the Role of RND Efflux Transporters in Burkholderia cenocepacia. 75
The role of RND efflux transporters in intrinsic antibiotic resistance of Burkholderia cenocepacia 73
The crystal structure of Burkholderia cenocepacia DfsA provides insights into substrate recognition and quorum sensing fatty acid biosynthesis 72
Design of Anti-infectious Agents from Lawsone in a Three-Component Reaction with Aldehydes and Isocyanides 71
Exploring the HME and HAE1 efflux systems in the genus Burkholderia 69
Vaccines to Overcome Antibiotic Resistance: The Challenge of Burkholderia cenocepacia 69
Antibiotics sustainability: another issue in the fight against antimicrobial resistance. 69
Identification of a New FtsZ Inhibitor by Virtual Screening, Mechanistic Insights, and Structure-Activity Relationship Analyses 69
Identification by Reverse Vaccinology of Three Virulence Factors in Burkholderia cenocepacia That May Represent Ideal Vaccine Antigens 65
The Evolution of Antimicrobial Resistance in Acinetobacter baumannii and New Strategies to Fight It 64
Quorum sensing as antivirulence target in cystic fibrosis pathogens 64
Mycobacterium tuberculosis efflux pumps: an update 63
Illumina-based chemogenomic profiling of a novel compound with antimicrobial activity reveals its role as a cell division inhibitor. 63
Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa MDR clinical isolates. 61
Recent advances to combat ESKAPE pathogens with special reference to essential oils 60
Molecular Mechanisms of Chlorhexidine Tolerance in Burkholderia cenocepacia Biofilms. 57
The novel drug candidate VOMG kills Mycobacterium abscessus and other pathogens by inhibiting cell division. 56
The role of RND efflux transporters in Burkholderia cenocepacia life. 55
Structural plasticity and distinct drug-binding modes of LfrR, a mycobacterial efflux pump regulator. 54
THERAPEUTIC STRATEGIES TO COMBAT STAPHYLOCOCCUS AUREUS INFECTIONS IN CYSTIC FIBROSIS 53
PEGylated mucus-penetrating nanocrystals for lung delivery of a new FtsZ inhibitor against Burkholderia cenocepacia infection 53
Various evolutionary trajectories lead to loss of the tobramycin-potentiating activity of the quorum sensing inhibitor baicalin hydrate in Burkholderia cenocepacia biofilms 51
The Effect of 2-Thiocyanatopyridine Derivative 11026103 on Burkholderia Cenocepacia: Resistance Mechanisms and Systemic Impact 49
Phenylacetyl-CoA, not phenylacetic acid, attenuates CepIR-regulated virulence in Burkholderia cenocepacia 49
New antivirulence compounds affecting Burkholderia cenocepacia quorum sensing in vitro and in vivo. 48
New Antimicrobial Strategies to Treat Multi-Drug Resistant Infections Caused by Gram-Negatives in Cystic Fibrosis 44
Subfunctionalization influences the expansion of bacterial multidrug antibiotic resistance 43
Lessons from Vibrio Pathogen and the Comparative Study of Vaccines Developed 35
Editorial: Community series in insights into new strategies to combat biofilms, volume II 34
Editorial: Insights Into New Strategies to Combat Biofilms 32
Editorial: Evolution of Genetic Mechanisms of Antibiotic Resistance 25
Editorial: Burkholderia spp.-transmission, pathogenesis, host-pathogen interaction, prevention and treatment 21
Synthesis, structural characterization, and biological evaluation of cinnamaldehyde–azomethine hybrids: In Vitro and In Silico approaches 15
Liposomal tobramycin and ceftazidime as advanced nanocarriers against Pseudomonas aeruginosa infections 8
Totale 7.603
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.938
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.938
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021314 0 0 0 0 0 53 1 103 28 60 56 13
2021/2022362 7 5 1 17 11 12 9 20 18 11 57 194
2022/20231.329 127 113 12 125 126 119 12 83 557 7 29 19
2023/2024569 62 89 19 30 40 119 26 60 5 40 46 33
2024/20251.533 23 101 44 32 64 87 116 94 384 65 196 327
2025/20261.930 301 201 406 389 498 135 0 0 0 0 0 0
Totale 7.603